CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$1.54
-0.09 (-5.52%)
As of Aug 13, 10:15 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,039.0% upside
Low Target $29.39
Average Target $48.34
High Target $58.89
Current Price $1.54
Current
$1.54
Target
$48.34
$29.39 $48.34 avg $58.89
Scenario Analysis
Bear Case
$29.39
1,808.4%
Low target
Base Case
$48.34
+3,039.0%
Avg target
Bull Case
$58.89
+3,724.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$116.00
-98.7% from high
52-Week Low
$1.48
+4.1% from low
Target vs 52W High
$48.34
-58.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.2%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.8%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.8%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%